Inventor

FONTENAY MICHAELA

FR6 patents

⚠️ This page may combine multiple inventors who share the name “FONTENAY MICHAELA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INST NAT SANTE RECH MED

2 patents

US10662482B2May 26, 2020

TET2 as a diagnostic and prognostic marker in hematopoietic neoplasms

INST NAT SANTE RECH MED1 citations68

US11203788B2Dec 21, 2021

TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms

INST NAT SANTE RECH MED0 citations58

VIGUIE FRANCK

2 patents

US9389233B2Jul 12, 2016

TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms

VIGUIE FRANCK3 citations65

US9297046B2Mar 29, 2016

TET2 as a new diagnostic and pronostic marker in hematopoietic neoplasms

VIGUIE FRANCK0 citations44

APOGENIX GMBH

1 patent

US9540431B2Jan 10, 2017

Inhibitors of the CD95 signaling pathway for treatment of MDS

APOGENIX GMBH0 citations46

INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)

1 patent

US9675590B2Jun 13, 2017

Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes

INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)0 citations40